Epoetin alfa every four weeks vs with every two weeks
Number of deaths · anaemia in predialysis patients
Epoetin alfa every four weeks showed no clear difference in number of deaths compared with with every two weeks (low certainty).
1 finding from 1 review
- Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients 2017 · Cochrane Headline outcomes onlyRR 0.95 [0.33, 2.75]3 studies · 724 participantsLow